Close Menu
New York Examiner News

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Brent Faiyaz Announces 2026 Tour Dates

    September 24, 2026

    Kalshi’s valuation is $23 billion to $42 billion according to Pitchbook

    September 24, 2026

    Clear Skies and Breezy Conditions Expected Thursday

    September 24, 2026
    Facebook X (Twitter) Instagram
    New York Examiner News
    • Home
    • US News
    • Politics
    • Business
    • Science
    • Technology
    • Lifestyle
    • Music
    • Television
    • Film
    • Books
    • Contact
      • About
      • Amazon Disclaimer
      • DMCA / Copyrights Disclaimer
      • Terms and Conditions
      • Privacy Policy
    New York Examiner News
    Home»Science»Ebola outbreak triggers U.S. ban on travelers from three African nations
    Science

    Ebola outbreak triggers U.S. ban on travelers from three African nations

    By AdminMay 18, 2026
    Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Ebola outbreak triggers U.S. ban on travelers from three African nations


    May 18, 2026

    2 min read

    Google Logo Add Us On GoogleAdd SciAm

    U.S. bans travel from three African countries as Ebola outbreak spreads

    At least six Americans are believed to have been exposed to the Ebola virus, and one person who appears to have contracted the virus has been evacuated to Germany

    By Adam Kovac edited by Claire Cameron

    A visitor washes his hands before entering Kyeshero Hospital at a checkpoint for hand washing and temperature screening for all visitors and patients entering Kyeshero Hospital, as part of Ebola prevention measures in Goma on May 18, 2026.

    Photo by Jospin Mwisha / AFP via Getty Images

    The U.S. on Monday announced new travel restrictions on visitors from three African nations—Uganda, South Sudan and the Democratic Republic of the Congo (DRC), which are at the center of an ongoing outbreak of Ebola virus that is believed to have killed at least 100 people. The ban, which doesn’t apply to U.S. citizens or permanent residents, will remain in place for 30 days. At least six Americans are known to have been exposed to the virus in the DRC; one of these people developed symptoms and has been evacuated to Germany, according to U.S. officials.

    In an order signed by acting Centers for Disease Control and Prevention (CDC) head Jay Bhattacharya, the agency says the ban aims to minimize the potential for spillover into the U.S. and to buy officials time to assess the threat of the outbreak, which the World Health Organization (WHO) on Sunday declared a global health emergency. While there have been just a dozen or so confirmed infections, hundreds more are suspected.

    The U.S. will also step up health screening, and the CDC will try to contact trace anyone who may have entered the country in recent weeks that could have had any exposure to Ebola. The risk to the general public remains low, the agency said in a press conference on Monday.


    On supporting science journalism

    If you’re enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


    The outbreak appears to be driven by the Bundibugyo virus, one of several viruses that can cause Ebola disease. The most notable symptom is viral hemorrhagic fever, which can cause life-threatening internal bleeding. This type of Ebola is similar to but not the same as the Zaire strain of the virus, which caused the 2013–2016 Ebola epidemic in West Africa that killed at least 11,325 people. The mortality rate for Bundibugyo is 25 percent to 50 percent, according to the CDC, and there is no vaccine or specific therapeutic for the disease.

    It’s Time to Stand Up for Science

    If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

    I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

    If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

    In return, you get essential news, captivating podcasts, brilliant infographics, can’t-miss newsletters, must-watch videos, challenging games, and the science world’s best writing and reporting. You can even gift someone a subscription.

    There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.



    Original Source Link

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Previous ArticleGod Of War’s New Lead Character Has Gamers Torn
    Next Article Elon Musk Loses Landmark Lawsuit Against OpenAI

    RELATED POSTS

    Blood test for multiple cancers clears crucial hurdle on track to FDA approval

    September 24, 2026

    A Startup Wants to Power Data Centers With ‘Supercritical’ Carbon Dioxide

    September 23, 2026

    Scientists discover largest new impact crater in the solar system ever—on our moon

    September 23, 2026

    Residents Harmed by Oil Drilling May Soon Receive Reparations Under New California Law

    September 22, 2026

    What a Trump order to put political appointees in charge of NIH funding would mean for science

    September 22, 2026

    After 8 Years in Space, ‘BepiColombo’ Is Finally Approaching Mercury

    September 21, 2026
    latest posts

    Brent Faiyaz Announces 2026 Tour Dates

    Brent Faiyaz has announced a run of US arena shows dubbed “I Spent the Night…

    Kalshi’s valuation is $23 billion to $42 billion according to Pitchbook

    September 24, 2026

    Clear Skies and Breezy Conditions Expected Thursday

    September 24, 2026

    Tennessee man sues police for arrest over filming, criticizing speeding officer

    September 24, 2026

    Vitamix Promo Codes and Deals: $25 Off + Free Shipping

    September 24, 2026

    Blood test for multiple cancers clears crucial hurdle on track to FDA approval

    September 24, 2026

    40th Rerelease Extends Run With Big Box Office

    September 24, 2026
    Categories
    • Books (1,509)
    • Business (6,413)
    • Events (76)
    • Film (6,347)
    • Lifestyle (4,412)
    • Music (6,477)
    • Politics (6,400)
    • Science (5,765)
    • Technology (6,346)
    • Television (6,037)
    • Uncategorized (9)
    • US News (6,400)
    popular posts

    Blood Orange Shares Video for New Song “The Field”: Watch

    Devonté Hynes is back with his first new Blood Orange song in three years. Hynes…

    How ‘One Battle After Another’ Channels Thomas Pynchon

    October 6, 2025

    Trouble, Atlanta Rapper, Shot Dead at 34

    June 6, 2022

    Venezuela interim government releases 4 Americans

    January 14, 2026
    Archives
    Browse By Category
    • Books (1,509)
    • Business (6,413)
    • Events (76)
    • Film (6,347)
    • Lifestyle (4,412)
    • Music (6,477)
    • Politics (6,400)
    • Science (5,765)
    • Technology (6,346)
    • Television (6,037)
    • Uncategorized (9)
    • US News (6,400)
    About Us

    We are a creativity led international team with a digital soul. Our work is a custom built by the storytellers and strategists with a flair for exploiting the latest advancements in media and technology.

    Most of all, we stand behind our ideas and believe in creativity as the most powerful force in business.

    What makes us Different

    We care. We collaborate. We do great work. And we do it with a smile, because we’re pretty damn excited to do what we do. If you would like details on what else we can do visit out Contact page.

    Our Picks

    Blood test for multiple cancers clears crucial hurdle on track to FDA approval

    September 24, 2026

    40th Rerelease Extends Run With Big Box Office

    September 24, 2026

    Abby Lee Miller Disses Former ‘Dance Moms’ Students

    September 24, 2026
    © 2026 New York Examiner News. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms & Conditions and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT